{"schema":"hottub-news/story/v1","story":"st_53w27dbu2i6w2ie5roua","title":"Aurobindo Pharma Receives USFDA Final Approval For Perampanel Tablets, Market Size Estimated At ₹558 Crore","title_en":null,"outlets":2,"brief":null,"page":"https://hottub.news/stories/aurobindo-pharma-receives-usfda-final-approval-for-perampanel-tablets-53w27dbu2i","count":2,"items":[{"id":"n_77pf2hm4dimgd6ejdljq","seq":1715434,"kind":"article","title":"Aurobindo Pharma receives USFDA Final Approval for Perampanel Tablets, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg","url":"https://www.equitybulls.com/category.php?id=376296","published":"2026-10-04T19:37:11Z","seen":"2026-10-04T19:37:11Z","lang":"en","source":{"id":"equitybulls.com","name":"equitybulls.com","domain":"equitybulls.com"},"via":"gdelt-gkg-english","topics":["economy","health","business"],"entities":[{"id":"Q4822431","name":"Aurobindo Pharma","type":"org"},{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_53w27dbu2i6w2ie5roua","category":"health","category_p":0.4399999976158142,"sentiment":"neutral","tone":0.15000000596046448,"political":0.07000000029802322},{"id":"n_53w27dbu2i6w2ie5roua","seq":1530914,"kind":"article","title":"Aurobindo Pharma Receives USFDA Final Approval For Perampanel Tablets, Market Size Estimated At ₹558 Crore","url":"https://www.freepressjournal.in/business/aurobindo-pharma-receives-usfda-final-approval-for-perampanel-tablets-market-size-estimated-at-558-crore","summary":"Mumbai: Aurobindo Pharma announced on October 3, 2026, that it has received final approval from the USFDA to manufacture and market Perampanel Tablets in 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg strengths. These tablets are bioequivalent and therapeutically equivalent to Fycompa® Tablets from Catalyst Pharmaceuticals, Inc. Market Opportunity The estimated market size for Perampanel Tablets stood at US$ 67 million (approximately ₹558 crore) for the twelve months ending August…","published":"2026-10-03T11:49:24Z","seen":"2026-10-03T12:29:27Z","lang":"en","country":"IN","source":{"id":"kite-freepressjournal-in-e26f41","name":"freepressjournal.in","domain":"freepressjournal.in","outlet":{"wikidata":"Q7735208","name":"The Free Press Journal","type":"newspaper","country":"IN","designations":["newspaper"]}},"via":"kite-freepressjournal-in-e26f41","topics":["business","topnews","fpj shorts","google"],"entities":[{"id":"Q4822431","name":"Aurobindo Pharma","type":"org"},{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q868658","name":"perampanel","type":"other"}],"image":"https://media.assettype.com/freepressjournal/2026-02-27/lcxioz3d/aurobindo-pharma.jpg?w=280","mentions":3,"story":"st_53w27dbu2i6w2ie5roua","category":"economy-business","category_p":0.800000011920929,"sentiment":"positive","tone":0.49000000953674316,"political":0.05000000074505806}]}